Trademark Overview
On Tuesday, July 9, 2024, a trademark application was filed for INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE with the United States Patent and Trademark Office. The USPTO has given the INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark a serial number of 98638765. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 9, 2024. This trademark is owned by The Ovarian Cancer Research Fund, Inc.. The INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:
Educational services in the nature of classes, seminars, forums, workshops, conferences and programs in the field of cancer research and education, and distributing educational materials in connection therewith; Publication of educational materials, namely, brochures and fact sheets for use in connection with educational services in the nature of classes, seminars, forums, workshops, conferences and programs in the field of cancer research and education; Providing on-line publications in the nature of brochures, fact sheets, frequently asked questions, webinars and audio-visual recording in the field of cancer research and education; providing training in the form of classes, workshops, and seminars in the field of cancer research and education; Conducting workshops and seminars in ovarian cancer awareness; Organizing, coordinating, arranging and conducting educational conferences in the field of cancer research and education.
Association services, namely, promoting public awareness of cancer research and education; promoting public awareness of cancer detection, research and treatments; promoting public interest in education and training for volunteers, professionals and others to help and support cancer patients and survivors; Lobbying services, namely, promoting the interests of ovarian cancer research and awareness programs in the fields of legislation and regulation; Lobbying services, namely, promoting the interests of legislation in the field of improving the quality of life and access to care for ovarian cancer patients; Public advocacy to promote awareness of ovarian cancer.
